Form 8-K - Current report:
SEC Accession No. 0001193125-25-173053
Filing Date
2025-08-05
Accepted
2025-08-05 08:00:23
Documents
58
Period of Report
2025-08-05
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d39256d8k.htm   iXBRL 8-K 24792
2 EX-99.1 d39256dex991.htm EX-99.1 46891
6 GRAPHIC g39256ex99_1p10g1.jpg GRAPHIC 206166
7 GRAPHIC g39256ex99_1p11g1.jpg GRAPHIC 229392
8 GRAPHIC g39256ex99_1p12g1.jpg GRAPHIC 266385
9 GRAPHIC g39256ex99_1p13g1.jpg GRAPHIC 264371
10 GRAPHIC g39256ex99_1p14g1.jpg GRAPHIC 279237
11 GRAPHIC g39256ex99_1p15g1.jpg GRAPHIC 272871
12 GRAPHIC g39256ex99_1p16g1.jpg GRAPHIC 219965
13 GRAPHIC g39256ex99_1p17g1.jpg GRAPHIC 163629
14 GRAPHIC g39256ex99_1p18g1.jpg GRAPHIC 257450
15 GRAPHIC g39256ex99_1p19g1.jpg GRAPHIC 234512
16 GRAPHIC g39256ex99_1p1g1.jpg GRAPHIC 298515
17 GRAPHIC g39256ex99_1p20g1.jpg GRAPHIC 180860
18 GRAPHIC g39256ex99_1p21g1.jpg GRAPHIC 255672
19 GRAPHIC g39256ex99_1p22g1.jpg GRAPHIC 267849
20 GRAPHIC g39256ex99_1p23g1.jpg GRAPHIC 140014
21 GRAPHIC g39256ex99_1p24g1.jpg GRAPHIC 292085
22 GRAPHIC g39256ex99_1p25g1.jpg GRAPHIC 291133
23 GRAPHIC g39256ex99_1p26g1.jpg GRAPHIC 210297
24 GRAPHIC g39256ex99_1p27g1.jpg GRAPHIC 198118
25 GRAPHIC g39256ex99_1p28g1.jpg GRAPHIC 318902
26 GRAPHIC g39256ex99_1p29g1.jpg GRAPHIC 178392
27 GRAPHIC g39256ex99_1p2g1.jpg GRAPHIC 371449
28 GRAPHIC g39256ex99_1p30g1.jpg GRAPHIC 277362
29 GRAPHIC g39256ex99_1p31g1.jpg GRAPHIC 253519
30 GRAPHIC g39256ex99_1p32g1.jpg GRAPHIC 286158
31 GRAPHIC g39256ex99_1p33g1.jpg GRAPHIC 190893
32 GRAPHIC g39256ex99_1p34g1.jpg GRAPHIC 251385
33 GRAPHIC g39256ex99_1p35g1.jpg GRAPHIC 241197
34 GRAPHIC g39256ex99_1p36g1.jpg GRAPHIC 145724
35 GRAPHIC g39256ex99_1p37g1.jpg GRAPHIC 323181
36 GRAPHIC g39256ex99_1p38g1.jpg GRAPHIC 293428
37 GRAPHIC g39256ex99_1p39g1.jpg GRAPHIC 249406
38 GRAPHIC g39256ex99_1p3g1.jpg GRAPHIC 256720
39 GRAPHIC g39256ex99_1p40g1.jpg GRAPHIC 207192
40 GRAPHIC g39256ex99_1p41g1.jpg GRAPHIC 241115
41 GRAPHIC g39256ex99_1p42g1.jpg GRAPHIC 149376
42 GRAPHIC g39256ex99_1p43g1.jpg GRAPHIC 256041
43 GRAPHIC g39256ex99_1p44g1.jpg GRAPHIC 230916
44 GRAPHIC g39256ex99_1p45g1.jpg GRAPHIC 179673
45 GRAPHIC g39256ex99_1p4g1.jpg GRAPHIC 305471
46 GRAPHIC g39256ex99_1p5g1.jpg GRAPHIC 230235
47 GRAPHIC g39256ex99_1p6g1.jpg GRAPHIC 218926
48 GRAPHIC g39256ex99_1p7g1.jpg GRAPHIC 139806
49 GRAPHIC g39256ex99_1p8g1.jpg GRAPHIC 248384
50 GRAPHIC g39256ex99_1p9g1.jpg GRAPHIC 273504
  Complete submission text file 0001193125-25-173053.txt   15148638

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA wve-20250805.xsd EX-101.SCH 2873
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE wve-20250805_lab.xml EX-101.LAB 17925
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wve-20250805_pre.xml EX-101.PRE 11253
60 EXTRACTED XBRL INSTANCE DOCUMENT d39256d8k_htm.xml XML 3613
Mailing Address 733 CONCORD AVENUE CAMBRIDGE MA 02138
Business Address 7 STRAITS VIEW #12-00, MARINA ONE EAST TOWER SINGAPORE U0 018936 617-949-2900
Wave Life Sciences Ltd. (Filer) CIK: 0001631574 (see all company filings)

EIN.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37627 | Film No.: 251182860
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)